Connect Biopharma Holdings (CNTB) EBIT (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted EBIT of -$19.6 million for Q1 2026, down 26.28% sequentially from -$15.5 million in Q4 2025, and down 71.29% YoY from -$68.3 million in Q1 2025.
Connect Biopharma Holdings (CNTB) EBIT (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported EBIT for 3 years, with the latest figure at -$19.6 million in Q1 2026.
- Quarterly EBIT fell 71.29% year-over-year to -$19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.2 million (down 211.45% YoY) and the FY2025 annual result came in at -$58.1 million, down 158.66% from the prior year.
- EBIT declined to -$19.6 million in Q1 2026 per CNTB's latest filing, from -$15.5 million in the prior quarter.
- Over five years, EBIT peaked at $13.6 million in Q2 2024 and troughed at -$19.6 million in Q1 2026.
- A 3-year average of -$11.1 million and a median of -$13.4 million in 2025 frame the typical range for EBIT.
- The widest YoY moves for EBIT: up 9.39% in 2025, down 198.37% in 2025.
- Over 3 years, EBIT stood at -$9.6 million in 2024, then slumped by 61.41% to -$15.5 million in 2025, then decreased by 26.28% to -$19.6 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$19.6 million, -$15.5 million, and -$17.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Connect Biopharma Holdings | 144.32 Mn | 144.32 Mn | - | -17.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.60 Mn |
| Mar 31, 2026 | -19.61 Mn |
| Dec 31, 2025 | -15.53 Mn |
| Sep 30, 2025 | -17.68 Mn |
| Jun 30, 2025 | -13.42 Mn |
| Mar 31, 2025 | -11.45 Mn |
| Dec 31, 2024 | -9.62 Mn |
| Sep 30, 2024 | -13.85 Mn |
| Jun 30, 2024 | 13.65 Mn |
| Mar 31, 2024 | -12.63 Mn |